Altimmune ALT
$ 8.61
2.44%
Quarterly report 2024-Q3
added 11-12-2024
Altimmune Cash Flow 2011-2024 | ALT
Annual Cash Flow Altimmune
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-75.8 M | -62.6 M | -78.2 M | -34.3 M | -9.6 M | -9.39 M | -20.2 M | - | - | - | - | -2.32 M | -7.81 M |
Depreciation & Amortization |
477 K | 493 K | 551 K | 429 K | 387 K | 219 K | 83.8 K | 63.1 K | 142 K | 150 K | 182 K | 304 K | 461 K |
Accounts Payables |
2.07 M | 4.8 M | 2.03 M | 612 K | 18.2 K | 373 K | 129 K | 927 K | 521 K | 391 K | 1.13 M | 1.7 M | 1.45 M |
Accounts Receivables |
1.11 M | 173 K | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Altimmune
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -19.4 M | - | -45.3 M | -30.2 M | -13.5 M | - | -56.3 M | -38.5 M | -19.6 M | - | -21 M | -11.5 M | -4.35 M | - | -7.6 M | -5.17 M | -2.11 M | - | -4.23 M | -3.21 M | -3.56 M | - | -15.4 M | -11.1 M | - | - | - | - | - | - | - | - | -2.71 M | - | - | -2.83 M | -2.29 M | - | -912 K | -235 K | 260 K | - | -178 K | -1.91 M | 791 K | - | -7 M | -3.39 M | -2.09 M |
Depreciation & Amortization |
- | - | - | - | - | -356 K | - | 31 K | 172 K | 119 K | - | 434 K | 149 K | 74 K | - | 219 K | 146 K | 73.4 K | - | 181 K | 122 K | 61.3 K | - | 146 K | 77.5 K | 25.1 K | - | 61.2 K | 37.8 K | 13 K | - | 32.2 K | 40.4 K | 37.7 K | - | 35 K | 36.7 K | 37.1 K | - | 37.1 K | 36.2 K | 39.9 K | - | 44.6 K | 41.9 K | 52.6 K | - | 72.5 K | 76.4 K | 85.9 K | - | 114 K | 117 K | 118 K |
Accounts Payables |
1.13 M | 2.69 M | 2.07 M | 3.05 M | 4.04 M | 5.24 M | 4.8 M | 1.42 M | 2.87 M | 2.2 M | 2.03 M | 6.08 K | 1.42 M | 418 K | 612 K | 612 K | 612 K | 612 K | 18.2 K | 18.2 K | 18.2 K | 18.2 K | 373 K | 373 K | 373 K | 373 K | 129 K | 129 K | 129 K | 129 K | 2.01 M | 2.01 M | 2.01 M | 927 K | 521 K | 521 K | 521 K | 521 K | 391 K | 391 K | 391 K | 391 K | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M |
Accounts Receivables |
428 K | 424 K | 1.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 M | - | - | - | - | - | - | - | - | 400 K | - | - | - | 3.6 M | - | - | - | - | - | - | - | 4.87 M | 4.04 M | 4.38 M | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency